Legal status · Australia
Is Sermorelin / GHRP legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Sermorelin / GHRP is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 5 human studies are cited on its profile.
Sermorelin / GHRP in Australia at a glance
| Classification | Not approved |
|---|---|
| Note | Not approved. Prohibited in sport by class (WADA S2). |
| TGA approval status | Not approved by TGA |
| Human studies cited | 5 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Sermorelin / GHRP profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing Sermorelin / GHRP is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What Sermorelin / GHRP is
The standard compounding pharmacy growth hormone blend, usually sold as 5 mg sermorelin with 5 mg GHRP-2 in one 10 mg vial. This is the only blend on this site where the class combination has genuine human data: adding a GHRH to GHRP-6 roughly doubled the acute growth hormone peak, 54.7 against 25.7 micrograms per litre in 20 patients. That was a single intravenous diagnostic test in a hospital, not a nightly subcutaneous protocol, and the specific vial has never been studied.
Sermorelin plus a growth hormone releasing peptide is the oldest configuration of this idea and the one with the most real science underneath it. Sermorelin is GHRH 1-29, the shortest fully active fragment of growth hormone releasing hormone, and it was an FDA-approved drug marketed as Geref for diagnosing and treating growth hormone deficiency before it was discontinued.
Mechanism: Sermorelin activates the pituitary GHRH receptor, raising growth hormone pulse amplitude while preserving hypothalamic feedback. GHRP-2 and GHRP-6 activate the growth hormone secretagogue receptor GHS-R1a, a separate receptor cloned in 1996, releasing growth hormone and suppressing somatostatin tone.
Regulatory history: Not approved as a blend. Sermorelin was previously FDA-approved as Geref and is now supplied compounded; GHRP-2 is approved in Japan as a diagnostic agent only; GHRP-6 is not approved anywhere.
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Sermorelin / GHRP at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Sermorelin / GHRP in other countries
Frequently asked questions
Is Sermorelin / GHRP legal in Australia?
No. Sermorelin / GHRP is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 5 human studies are cited on its profile. Note: Not approved. Prohibited in sport by class (WADA S2).
Can I buy Sermorelin / GHRP in Australia?
No approved product exists to buy. In Australia Sermorelin / GHRP is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Not approved. Prohibited in sport by class (WADA S2).
Is Sermorelin / GHRP TGA approved?
No. In Australia Sermorelin / GHRP is classified as "Not approved", which is not a TGA marketing approval. For comparison, the US FDA status is: Not approved as a blend. Sermorelin was previously FDA-approved as Geref and is now supplied compounded; GHRP-2 is approved in Japan as a diagnostic agent only; GHRP-6 is not approved anywhere.. On the evidence, 5 human studies are cited on its profile.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Sermorelin / GHRP live on its compound profile.
Sermorelin / GHRP profileThis page is general information about the regulatory status of Sermorelin / GHRP in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.